Filing Flows › Tandem Diabetes Care (TNDM) › Supplies and other revenue
Tandem Diabetes Care (TNDM) Supplies and other revenue by quarter
Tandem Diabetes Care's Supplies and other revenue was $169M in Q3 2026 (third quarter 2026), +21% from Q2 2026. Over the last 7 quarters it ranged from $129M (Q2 2025) to $169M (Q3 2026).
| Quarter | Supplies and other revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $169M | +21% | +21% |
| Q2 2026 | $140M | +2% | +9% |
| Q1 2026 | $137M | -9% | +3% |
| Q4 2025 | $150M | +8% | — |
| Q3 2025 | $139M | +8% | — |
| Q2 2025 | $129M | -3% | — |
| Q1 2025 | $132M | — | — |
Q3 2026 at a glance
Tandem Diabetes Care, Q3 2026: revenue $284M (+14% year over year), operating margin -0.8%, net loss $7.1M, operating cash flow −$819K. The chart follows the revenue to costs, profit and cash.
Questions
What is Tandem Diabetes Care's Supplies and other revenue?
Tandem Diabetes Care's Supplies and other revenue was $169M in Q3 2026 (third quarter 2026), +21% from Q2 2026.
How has Tandem Diabetes Care's Supplies and other revenue changed?
Over the last 7 quarters it ranged from $129M (Q2 2025) to $169M (Q3 2026).